The review concerns the role of reactive oxygen species as physiological second messengers in potentiating G-protein-coupled receptor-mediated vasoconstriction and its potential dysregulation by oxidant stress in pulmonary hypertension. r What advances does it highlight?
Introduction
Pulmonary hypertension (PH) is associated with oxidant stress and increased generation of reactive oxygen (ROS) and nitrogen species (RNS). There is a long line of evidence to suggest that these contribute to the aetiology of PH, and there has consequently been significant interest in the potential for antioxidant therapies (Hansen et al. 2016) . However, unless precisely targeted, such therapies could have unpredictable effects, as ROS are also important physiological second messengers (Droge, 2002) . Reactive oxygen species are known to affect the function of numerous protein kinases, phosphatases and ion channels in the systemic and pulmonary vasculatures, either directly or indirectly via regulatory proteins (Bogeski et al. 2011; Knock & Ward, 2011; Konior et al. 2014) . However, the difficulties in quantifying ROS in situ (particularly in small signalling domains) make it uncertain as to whether some of these described effects are physiologically rather than pathologically significant.
Reactive oxygen species originate from the transfer of an electron to molecular O 2 to form the superoxide radical (SO • ). The superoxide radical can directly oxidize protein cysteine and methionine residues and reacts with nitric oxide (NO • ) to produce peroxynitrite (ONOO − ), which modifies protein tyrosines to form nitrotyrosines. It is transmuted by superoxide dismutase (SOD) to hydrogen peroxide (H 2 O 2 ), which is subsequently reduced to water by catalase or glutathione peroxidase, or converted by the Fenton reaction to the extremely reactive and very short-lived hydroxyl radical. Hydrogen peroxide is more stable and mobile than SO
• and is generally regarded as the most important ROS signalling moiety. Many oxidoreductase enzymes generate SO
• , including uncoupled nitric oxide synthase and xanthine oxidase, both of which contribute to oxidant stress in PH. However, the main sources of ROS in the vasculature are the nicotinamide adenine dinucleotide phosphate oxidases [NADPH oxidase (NOX); Konior et al. 2014] and mitochondria (Daiber et al. 2017) . Although there remains some controversy, it is widely believed that hypoxic pulmonary vasoconstriction (HPV) involves increased generation of ROS by mitochondria, which act as second messengers to initiate vasoconstriction; they also contribute to chronic hypoxia-induced PH (Waypa et al. 2001; Sylvester et al. 2012; Adesina et al. 2015) .
With the exception of HPV, NOX isoforms are the most important source of ROS for both physiological cell signalling and PH-associated oxidant stress, although there may be significant cross-talk between mitochondria and NOX in relation to ROS signalling (Daiber et al. 2017) . Pulmonary vascular smooth muscle expresses NOX1, NOX2 and NOX4 (Konior et al. 2014) . The archetypical isoform NOX2 (gp91 phox ) combines with p22 phox in the membrane and is activated on binding of the cytosolic subunits p47 phox (organizer subunit) and p67 phox (activator subunit), which is itself activated by the small GTPase Rac1 (Fig. 1) . NOX1 is similar, but can also use the p47 phox and p67 phox analogues NOXO1 and NOXA1. Unlike NOX1 and NOX2, NOX4 does not require cytosolic subunits and is constitutively active; its regulation is primarily via altered expression (Konior et al. 2014) . Whereas NOX1 is localized to caveolae in vascular smooth muscle cell membranes, NOX4 is associated with focal adhesions, presumably reflecting different signalling domains and functions (Hilenski et al. 2004) . Increased expression and activity of NOX1 and NOX4 have been described in PH (both chronic hypoxia and PAH), with both contributing to oxidant stress, although NOX1 seems to have a pre-eminent role in pulmonary vascular remodelling, where NOX4 may contribute to depolarization via ROS-mediated inhibition of voltage-activated potassium (K V ) channels, with which it co-localizes (Mittal et al. 2012; Veit et al. 2013; Hood et al. 2016) .
Physiological regulation of ROS and ion channels
Many G-protein-coupled receptor (GPCR) vasoconstrictor agonists activate NOX and increase ROS generation, including prostanoids, endothelin-1, ATP and adenosine, sphingolipids and the classical NOX activator angiotensin II (Wedgwood et al. 2001; Madamanchi et al. 2005; Chakraborti et al. 2009; El-Awady et al. 2011; Shaifta et al. 2015) . A common (but not sole) pathway involves activation of protein kinase C (PKC) by phospholipase C (PLC)-derived diacylglycerol (DAG) and/or raised [Ca 2+ ], and subsequent phosphorylation of p47 phox (Li & Shah, 2003; Chakraborti et al. 2009; Konior et al. 2014) . Antioxidants, SOD, catalase and inhibition of NOX at least partly reverse GPCR-mediated vasoconstriction or the associated elevation in intracellular [Ca 2+ ] (Chakraborti et al. 2009; El-Awady et al. 2011; Shaifta et al. 2015) . We have found that the selective NOX inhibitor VAS 2870 strongly suppresses U-46619 (thromboxane analogue)-induced contraction of small pulmonary arteries by 49 ± 1% (n = 7; V. A. Snetkov and J. P. T. Ward, unpublished observation), suggesting that NOX-derived ROS make a more important contribution to GPCR-mediated vasoconstriction than previously suspected.
Redox state and ROS affect the function of numerous ion channels, including various K + channels, voltage-gated Ca 2+ channels, and those comprised of members of the canonical transient receptor potential cation channels (TRPC) family, including store-(SOCs) and receptor-operated channels (ROCs). Acute effects are generally mediated through alteration of activation/inactivation kinetics, open-state times or channel availability rather than direct gating and, in the longer term, through altered expression (Bogeski et al. 2011; Olschewski & Weir, 2015; Malczyk et al. 2016) . Altered function and expression of several channel types are strongly implicated in the aetiology of PH (Mandegar et al. 2002; Yu et al. 2004; Boucherat et al. 2015; Olschewski & Weir, 2015) . In addition to Ca 2+ release from stores, vasoconstriction typically involves depolarization attributable to inhibition of K + channels and/or increased Na + and Ca 2+ entry through non-selective cation channels (ROCs and SOCs), and consequent Ca 2+ entry via voltage-dependent L-type Ca 2+ channels. The question arises as to whether these classical mechanisms are physiologically modulated by concurrent GPCR-mediated ROS generation.
We have recently discovered a potentially important physiological role for ROS in regulating vascular smooth muscle Ca 2+ entry, facilitated by a serendipitous finding concerning the sphingolipid sphingosylphosphorylcholine (SPC). At concentrations >10 μM, SPC elicits a receptor-mediated vasoconstriction (Nixon et al. 2008) . However, at more physiological concentrations (ࣘ1 μM) we found that although it had no discernible effect on contraction or intracellular [ and vasoconstriction induced by mild depolarization or low concentrations of U-46619 (thromboxane analogue). This potentiation was dependent on PLC and PKC, but independent of Rho kinase, K + channel inhibition/depolarization and intracellular Ca 2+ stores (Snetkov et al. 2008) , raising the possibility that it could be related to NOX activation.
In subsequent studies, we have confirmed that this is indeed the case and have delineated a pathway with consecutive activation of PLC, PKCε (novel isoform, DAG dependent but Ca 2+ independent) and NOX1, with subsequent enhancement by ROS of Ca 2+ entry through L-type Ca 2+ channels (and probably ROCs; Shaifta et al. 2015) . Note that potentiation occurred only once Ca 2+ entry had been activated by other means (e.g. depolarization); in these conditions, ROS did not initiate Ca 2+ entry itself. We speculate that all PLC-linked GPCRs (and thus the majority of vasoconstrictor agonists) may activate this pathway in parallel to those eliciting Ca 2+ entry, effectively amplifying the latter (Fig. 1) . This is consistent with a study by Chakraborti et al. (2009) , which reported that activation of NOX by U-46619 led to modulation of the K V voltage-gated Ca 2+ entry pathway in pulmonary artery smooth muscle cells and would explain the reported effects of antioxidants and NOX inhibition on GPCR-mediated vasoconstriction (see paragraph 4 above).
Interestingly, both PKCε and Src (also required for NOX1 activation, presumably by indirectly activating Rac1; Konior et al. 2014; Shaifta et al. 2015) and, possibly, PLC are themselves activated by ROS (Knock & Ward, 2011; MacKay & Knock, 2015) . Indeed, it has been proposed that in HPV, mitochondria-derived ROS activate NOX via PKCε, thus promoting voltage-gated Ca 2+ entry (Rathore et al. 2008) . This and the potentially central role of Src in mediating the multiple effects of ROS in PH imply a strong disposition towards positive feedback (Rathore et al. 2008; MacKay & Knock, 2015) . However, in physiological conditions any positive feedback must be insufficient to maintain NOX1 activation, as both GPCR-mediated vasoconstriction and HPV are rapidly reversible on removal of stimuli. This is presumably attributable to suppression by 'shielding' local antioxidant mechanisms and/or tight compartmentalization of ROS signalling. Notably, NOX1-derived ROS did not activate Rho kinase or Ca 2+ release from stores in the pulmonary artery (Snetkov et al. 2008) , although both exogenous and mitochondrially derived ROS do so (Knock et al. 2009; Sylvester et al. 2012) , again implying compartmentalization. Consistent with this, angiotensin II receptors, NOX, PKC and L-type channels are reported to be clustered in membrane microsignalling domains in the cerebral artery (Amberg et al. 2010) .
Conclusion and implications for pulmonary hypertension
In view of its multiple actions, it is not surprising that ROS signalling, like that for Ca 2+ , should be compartmentalized. However, this and the high propensity for positive feedback have significant implications for PH. We can speculate that in PH, oxidant stress associated with increased expression of NOX1, NOX4 and other ROS generators effectively dysregulates the normal compartmentalization of ROS signalling, leading to unfettered positive feedback and promiscuous and unco-ordinated actions that contribute to the aetiology (Fig. 1) . In particular, our studies and those of others suggest that an unconstrained elevation in ROS would strongly affect ion channel function and potentiate entry, contributing to the enhanced contractile and remodelling processes that are characteristic of PH. Indeed, elevation of intracellular [Ca 2+ ] also potentiates ROS generation by both NOX and mitochondria (Konior et al. 2014; Daiber et al. 2017) , potentially another positive feedback pathway. Although this supports proposals that targeted antioxidants could prove to be an effective therapy for PH, it also suggests that to be effective such therapies may have to be highly precise and target more than one mechanism if they are to supress the self-perpetuating nature of the oxidant stress without disruption of normal physiological signalling.
